Unlearn.AI is a developer of a platform designed to make computational clinical trials. The company's platform accelerates clinical trials by supplementing control groups with synthetic patient data generated using AI, which helps in reducing the time to develop new medicines, enabling healthcare companies to sooner provide patients in need with life-saving therapies. Creating AI to simulate biology and improve the lives of patients. Unlearn was founded by scientists, who wanted to find a new, evidence-based approach. We operate based on proprietary approaches to machine learning principles and regulatory guidances.
B2G, B2B
26 to 50
Series A
$12 M
Scaling Up
2017
Pharmaceuticals
Managed Health Care
Health Care Facilities & Hospitals
Computer Software
Biotechnology
N/A
Increase Efficiency
Analytics
IT and Security
Service
Yes
Active
Machine Learning
Machine Perception
Natural Language Processing
Knowledge Representation and Reasoning
N/A
Software
N/A
N/A
Senior Data Engineer
San Francisco, California
Data Scientist
San Francisco, California
Technical Product Manager
San Francisco, California
Senior DevOps Engineer
San Francisco, California
Recruiter
San Francisco, California
3
1
$3 M
Company was founded 2017 and it took almost 3 years (Nov 2020) to raise first external round
